SCHEMBL7672764

SCHEMBL7672764

Cc1ccc(Oc2ccc(Cl)cc2)c(Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 8/20 0.46
SLC6A4 P31645 8/20 0.46
KCNH2 Q12809 5/20 0.46
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
S1PR4 O95977 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
EGFR P00533 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7667163 0.87 ALDH1A1 (0.47) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL7667111 0.86 HTR2A (0.43) HTR2ASLC6A4KCNH2MEN1CYP1A2
SCHEMBL7666787 0.86 MAPT (0.43) HTR2ASLC6A4KCNH2MEN1ALDH1A1
SCHEMBL22199135 0.85 S1PR4 (0.51) HTR2ASLC6A4KCNH2KDM4EMEN1
SCHEMBL7659649 0.82 ADORA1 (0.34) HTR2ASLC6A4KCNH2S1PR4
SCHEMBL7666779 0.79 HTR2A (0.44) HTR2ASLC6A4KCNH2KDM4EMEN1
SCHEMBL7663772 0.79 S1PR4 (0.56) SLC6A4MAPTHPGDS1PR4PTGS1
SCHEMBL3949976 0.75 TGFBR1 (0.41) S1PR4SCN5ASCN9A
SCHEMBL7671126 0.75 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2
SCHEMBL7226169 0.74 ALDH1A1 (0.42) KDM4EMEN1ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed